Physician Assistant · West Orange, NJ
NPI
1215387386
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
347 Mount Pleasant Ave Ste 205
West Orange, NJ, 07052
Phone (973) 571-2121
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
3,886 services
Medicare patients, 2024
747
Average age 73
Drug cost, 2024
$674K
689 prescriptions
Company payments, 2025
$8,418
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicole Colucci was code 17003 (destruction skin lesion), 690 times for 126 patients. In total Nicole Colucci billed 3,886 services in 56 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 690 | 126 | $5.00 | $3,449 |
| 99213 Office E&M - Established | Office | 652 | 452 | $59.52 | $39K |
| 96910 Skin | Office | 368 | 36 | $87.46 | $32K |
| 17110 Destruction Skin Lesion | Office | 322 | 238 | $77.34 | $25K |
| 17000 Destruction Skin Lesion | Office | 307 | 232 | $35.39 | $11K |
| 11102 Skin Biopsy | Office | 297 | 252 | $58.38 | $17K |
| 99212 Office E&M - Established | Office | 123 | 109 | $38.59 | $4,747 |
| 99203 Office E&M - New | Office | 104 | 104 | $72.03 | $7,491 |
| 11103 Skin Biopsy | Office | 69 | 54 | $38.09 | $2,628 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 68 | 32 | $0.68 | $46.23 |
| 12031 Wound Repair - All Levels | Office | 66 | 53 | $180.45 | $12K |
| 11900 Skin | Office | 52 | 28 | $33.46 | $1,740 |
| 10040 Removal or Shaving of Skin Growth | Office | 43 | 42 | $69.87 | $3,004 |
| 17004 Destruction Skin Lesion | Office | 35 | 28 | $123.56 | $4,325 |
| 11602 Skin Lesion Excision | Office | 32 | 28 | $89.66 | $2,869 |
By year: 2022 $149K for 3,209 services; 2023 $191K for 3,917 services; 2024 $193K for 3,886 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicole Colucci prescribed most often to Medicare patients was Clobetasol Propionate, with 98 prescriptions and refills. In total Nicole Colucci wrote 689 Medicare prescriptions that cost $674K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 98 | 98 | 55 | $2,366 |
| Triamcinolone Acetonide Generic | 74 | 80 | 54 | $1,159 |
| Nystatin Generic | 60 | 60 | 32 | $482 |
| Ketoconazole Generic | 58 | 58 | 25 | $971 |
| Clindamycin Phosphate Generic | 50 | 50 | 17 | $1,776 |
| Mupirocin Generic | 46 | 46 | 34 | $273 |
| Prednisone Generic | 25 | 25 | 19 | $78.67 |
| Mometasone Furoate Generic | 23 | 23 | 19 | $383 |
| Doxycycline Hyclate Generic | 17 | 21 | 15 | $3,202 |
| Taltz Autoinjector Ixekizumab | 14 | 14 | Under 11 | $96K |
| Cosentyx (2 Syringes) Secukinumab | 12 | 12 | Under 11 | $157K |
| Doxycycline Monohydrate Generic | 11 | 11 | 11 | $85.23 |
| Glycopyrrolate Generic | 11 | 11 | Under 11 | $120 |
Brand drugs: 122 claims; generic drugs: 567 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicole Colucci $8,418 ($8,418 in general payments such as food, travel and fees) from 26 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $4,123.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 64 | $4,123 |
| Mayne Pharma Commercial LLC | 2 | $1,140 |
| Organon LLC OGN | 12 | $372 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $359 |
| Arcutis Biotherapeutics, Inc. ARQT | 38 | $317 |
| Galderma Laboratories, L.P. GALD.SW | 15 | $275 |
| Janssen Biotech, Inc. JNJ | 34 | $237 |
| Abbvie Inc. ABBV | 30 | $233 |
| Incyte Corporation INCY | 18 | $204 |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $188 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.